Search

everythinglearnresearchcommunity

for

Search:↓

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Higher prolactin levels are linked to psoriasis, alopecia areata, and vitiligo severity.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Certain gene changes in osteopontin are linked to higher risk of atopic dermatitis and asthma.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Exosome-based therapies show promise for treating alopecia areata but need more research.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Alopecia areata patients often have low vitamin D levels.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Adipose tissue therapies have advanced from tissue to cell and cell-free treatments, showing promise but also limitations.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

TS-13 speeds up hair regrowth after chemotherapy without affecting treatment effectiveness.

Atopic dermatitis increases the risk of some autoimmune diseases.

Neutrophils are important for causing chronic itch in atopic dermatitis, and blocking the CXCR3 receptor may reduce this itch.

Hejie Shengfa Decoction may help treat alopecia areata by promoting hair growth and reducing inflammation, but more safety studies are needed.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

Neutrophils are key in causing chronic itch in atopic dermatitis, and blocking CXCR3 could reduce this itch.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Alopecia areata patients have lower vitamin D levels than healthy individuals.